Aortic stenosis and mitral regurgitation: Implications for transcatheter valve treatment

EuroIntervention

Volumn 9, Issue , 2013, Pages S69-S71

  Barbanti, Marco ^a   Dvir, Danny ^a   Tan, John ^a   Webb, John G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aortic stenosis; Mitral regurgitation; Transcatheter aortic valve implantation

Indexed keywords

AORTIC STENOSIS; ARTICLE; HEART VALVE REPLACEMENT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISOLATED HEART; MITRAL VALVE REGURGITATION; MITRAL VALVE SURGERY; PREOPERATIVE TREATMENT; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; WORK EXPERIENCE; AORTA VALVE; AORTA VALVE STENOSIS; COMORBIDITY; DISEASE MANAGEMENT; HEART CATHETERIZATION; METHODOLOGY; MITRAL VALVE; REVIEW; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COMORBIDITY; DISEASE MANAGEMENT; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84903509394     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9SSA13     Document Type: Article

References (53)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-142.
3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur J Cardiothorac Surg. 2012;42:S1-44.
4. Arom KV, Nicoloff DM, Kersten TE, Northrup WF 3rd, Lindsay WG, Emery RW. Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg. 1989;98:1008-15.
5. Galloway AC, Grossi EA, Baumann FG, LaMendola CL, Crooke GA, Harris LJ, Colvin SB, Spencer FC. Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients. J Am Coll Cardiol. 1992;19:725-32.
6. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 1996;62:932-5.
7. Debétaz LF, Ruchat P, Hurni M, Fischer A, Stumpe F, Sadeghi H, van Melle G, Goy JJ. St. Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors. J Thorac Cardiovasc Surg. 1997;113:134-48.
8. Mueller XM, Tevaearai HT, Stumpe F, Fischer AP, Hurni M, Ruchat P, von Segesser LK. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg. 1998;115:1298-309.
9. Turina J, Stark T, Seifert B, Turina M. Predictors of the long-term outcome after combined aortic and mitral valve surgery. Circulation. 1999;100:48-53.
10. http://spo.escardio.org/eslides/view.aspx?eevtid=42&fp=637
11. Barreiro CJ, Patel ND, Fitton TP, Williams JA, Bonde PN, Chan V, Alejo DE, Gott VL, Baumgartner WA. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly. Impact on survival and functional outcome. Circulation. 2005;112:I443-7.
12. Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114:I541-6.
13. Caballero-Borrego J, Gómez-Doblas JJ, Cabrera-Bueno F, García-Pinilla JM, Melero JM, Porras C, Olalla E, De Teresa Galván E. Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement. Eur J Cardiothorac Surg. 2008;34:62-6.
14. Harling L, Saso S, Jarral OA, Kourliouros A, Kidher E, Athanasiou T. Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? Eur J Cardiothorac Surg. 2011;40:1087-96.
15. Absil B, Dagenais F, Mathieu P, Métras J, Perron J, Baillot R, Bauset R, Doyle D. Does moderate mitral regurgitation impact early mid-term clinical outcome in patients undergoing isolated aortic valve replacement for aortic stenosis? Eur J Cardiothorac Surg. 2003;24:217-22.
16. Coutinho GF, Correia PM, Pancas R, Antunes M. Management of moderate secondary mitral regurgitation at the time of aortic valve surgery. Eur J Cardiothorac Surg. 2013;44:32-40.
17. Vanden Eynden F, Bouchard D, El-Hamamsy I, Butnaru A, Demers P, Carrier M Perrault LP, Tardif JC, Pellerin M. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Ann Thorac Surg. 2007;83:1279-84.
18. Wan CK, Suri RM, Li Z, Orszulak TA, Daly RC, Schaff HV, Sundt TM 3rd. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary? J Thorac Cardiovasc Surg. 2009;137:635-40.
19. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400-6.
20. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20:1594-8.
21. Tunick PA, Gindea A, Kronzon I. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Am J Cardiol. 1990;65:1219-21.
22. Tassan-Mangina S, Metz D, Nazeyllas P, Torossian F, Pop C, Bertrand J, Baehrel B, Elaerts J. Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: a transthoracic and transesophageal prospective study. Clin Cardiol. 2003;26:127-31.
23. Unger P, Dedobbeleer C, Van Camp G, Plein D, Cosyns B, Lancellotti P. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart. 2010;96:9-14.
24. Unger P, Magne J, Vanden Eynden F, Plein D, Van Camp G, Pasquet A, Cosyns B, Dedobbeleer C, Lancellotti P. Impact of prosthesis-patient mismatch on mitral regurgitation after aortic valve replacement. Heart. 2010;96:1627-32.
25. Adams PB, Otto CM. Lack of improvement in coexisting mitral regurgitation after relief of valvular aortic stenosis. Am J Cardiol. 1990;66:105-7.
26. Brasch AV, Khan SS, DeRobertis MA, Kong JH, Chiu J, Siegel RJ. Change in mitral regurgitation severity after aortic valve replacement for aortic stenosis. Am J Cardiol. 2000;85:1271-4.
27. Moazami N, Diodato MD, Moon MR, Lawton JS, Pasque MK, Herren RL, Guthrie TJ, Damiano RJ. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Cardiac Surg. 2004;19:444-8.
28. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
29. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
30. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
31. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-63.
32. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-90.
33. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
34. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
35. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-15.
36. D'Errigo P, Barbanti M, Ranucci M, Onorati F, Covello RD, Rosato S, Tamburino C, Santini F, Santoro G, Seccareccia F; on behalf of the OBSERVANT Research Group. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol. 2012 May 25. [Epub ahead of print].
37. Barbanti M, Webb JG, Hahn R, Thompson C, Feldman T, Kodali S, Green P, Hueter I, Smith CS, Zajarias A, Babaliaros V, Makkar R, Szeto W, Alu M, Miller DC, Leon MB. Impact of preoperative moderate/severe mitral regurgitation on patients undergoing percutaneous and surgical aortic valve replacement: insights from the PARTNER trial. J Am Coll Cardiol. 2013;61:10S.
38. D'Onofrio A, Gasparetto V, Napodano M, Bianco R, Tarantini G, Renier V, Isabella G, Gerosa G. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1271-6.
39. Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L, Bagur R, Willson AB, Binder RK, Gurvitch R, Grewal J, Moss R, Munt B, Thompson CR, Freeman M, Ye J, Cheung A, Dumont E, Wood DA, Webb JG. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol. 2012;59:2068-74.
40. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, Llano MF, Chu J, Anumandla AK, Rodriguez LL, Mack MJ, Hanzel G, Kodali SK, Hung J, Picard MH. Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis. 2011;20:272-81.
41. Tzikas A, Piazza N, van Dalen BM, Schultz C, Geleijnse ML, van Geuns RJ, Galema TW, Nuis RJ, Otten A, Gutierrez-Chico JL, Serruys PW, de Jaegere PP. Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:43-9.
42. Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr. 2012;25:160-5.
43. Unger P, Dedobbeleer C, Vanden Eynden F, Lancellotti P. Mitral regurgitation after transcatheter aortic valve replacement: does the prosthesis matter? Int J Cardiol. 2013 Apr 11. [Epub ahead of print].
44. De Chiara B, Moreo A, De Marco F, Musca F, Oreglia J, Lobiati E, Bruschi G, Belli O, Mauri F, Klugmann S. Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients. Catheter Cardiovasc Interv. 2011;78:638-44.
45. Chieffo A, Buchanan GL, Van Mieghem NM, Tchetche D, Dumonteil N, Latib A, van der Boon RM, Vahdat O, Marcheix B, Farah B, Serruys PW, Fajadet J, Carrié D, de Jaegere PP, Colombo A. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol. 2013;61:830-6.
46. Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F, Schalij MJ, Baan J Jr, Cocchieri R, Brueren GR, van Straten AH, den Heijer P, Bentala M, van Ommen V, Kluin J, Stella PR, Prins MH, Maessen JG, Prinzen FW. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720-8.
47. Alizadeh A, Sanati HR, Haji-Karimi M, Yazdi AH, Rad MA, Haghjoo M, Emkanjoo Z. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace. 2011;13:1587-90.
48. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol. 2007;50:2071-7.
49. Barbanti M, Ussia GP, Tamburino C. Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases description. Catheter Cardiovasc Interv. 2011;78:650-5.
50. Madder RD, Safian RD, Gallagher M, Senter SR, Hanzel GS. The first report of transcatheter aortic valve implantation and percutaneous mitral valve repair in the same patient. JACC Cardiovasc Interv. 2011;4:824.
51. Ong SH, Beucher H, Mueller R, Gerckens U, Boekstegers P. Percutaneous double-valve interventions for aortic stenosis and pure mitral regurgitation. Am J Cardiol. 2011;108:893-5.
52. Rudolph V, Schirmer J, Franzen O, Schlüter M, Seiffert M, Treede H, Reichenspurner H, Blankenberg S, Baldus S. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol. 2012 Mar 27. [Epub ahead of print].
53. Kische S, D'Ancona G, Paranskaya L, Schubert J, Arsoy N, Hauenstein KH, Alozie A, Jovanovich B, Nienaber C, Ince H. Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: institutional experience. Catheter Cardiovasc Interv. 2013 Jan 29. [Epub ahead of print].